Literature DB >> 31092529

Venous thromboembolism.

Susan Shapiro1, Tamara Everington2, Lara Roberts3, Roopen Arya3.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31092529      PMCID： PMC6542237          DOI： 10.7861/clinmedicine.19-3-262a

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


× No keyword cloud information.
  3 in total

1.  Reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism in medical inpatients.

Authors:  Gerard Stansby; Ian Donald
Journal:  Clin Med (Lond)       Date:  2019-03       Impact factor: 2.659

2.  A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group.

Authors:  M M Samama; A T Cohen; J Y Darmon; L Desjardins; A Eldor; C Janbon; A Leizorovicz; H Nguyen; C G Olsson; A G Turpie; N Weisslinger
Journal:  N Engl J Med       Date:  1999-09-09       Impact factor: 91.245

3.  Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.

Authors:  Alain Leizorovicz; Alexander T Cohen; Alexander G G Turpie; Carl-Gustav Olsson; Paul T Vaitkus; Samuel Z Goldhaber
Journal:  Circulation       Date:  2004-08-02       Impact factor: 29.690
  3 in total
  2 in total

1.  VTE prophylaxis for medical patients when they leave hospital: a wider approach to future research and evidence is required.

Authors:  John Dean
Journal:  Clin Med (Lond)       Date:  2020-01       Impact factor: 2.659

2.  What is the cost of implementing updated NICE guidance (2018) on venous thromboembolism prophylaxis post hospital discharge for medical patients?

Authors:  Will Thomas; Tina Sleep; Amy Forbes McNeil; Stephen Wallis
Journal:  Clin Med (Lond)       Date:  2019-09       Impact factor: 5.410
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.